ProShares Ultra Nasdaq Biotechnology 2X Shares

BIBNASDAQ · USD
117.48USD+4.82 (+4.27%)

ProShares Ultra Nasdaq Biotechnology 2X Shares (BIB) Option Chain

Read more

Tracking the BIB option chain helps you see every strike and expiry on ProShares Ultra Nasdaq Biotechnology 2X Shares in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of BIB options activity at a glance. Use our scanner to monitor the BIB option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For BIB stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where BIB options are being actively traded, and where they are not.

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
28.5480-2.4312.488.5011.60105.00-6.800.502.850.001.680571.46
43.50940-0.437.486.008.10110.00-2.362.004.700.003.350956.50
58.782702.222.483.206.20115.00+2.084.807.600.006.200141.22
72.272103.000.001.604.40120.00+6.528.1011.202.527.130027.73
82.761602.500.000.804.20125.00+10.9511.6014.607.525.580017.24

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

  • IndustryExchange Traded Fund
  • SectorFinancial
  • IV Rank96.43% High
  • Market cap (M$)—
  • 52 weeks high-10.87%
  • 52 weeks low66.90%
  • Analyst recommendation—
  • Target price—
  • Dividend—
  • Payout ratio—
  • Earnings date—
  • P/E—
  • Future P/E—
  • EPS (ttm)—
  • EPS growth next 5 years—

As of Nov 5, 2026